Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Residual Lesions”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Early research (Phase 1)Looking for participantsNCT05240950
What this trial is testing

Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases

Who this might be right for
Colorectal CancerMetastatic Liver Cancer
Changhai Hospital 18
Not applicableUnknownNCT05310357
What this trial is testing

Chromosomal Instability in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerHigh-grade Serous Ovarian CarcinomaChromosomal Instability+5 more
Lei Li 300
Not applicableLooking for participantsNCT07006012
What this trial is testing

RGL-305+ Lymphoma + Exploratory Clinical Study

Who this might be right for
Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University 12